BeOne Medicines AG (HKG:6160)
Hong Kong · Delayed Price · Currency is HKD 225.80
-5.60 (-2.42%)
Oct 22, 2026, 1:00 PM HKT
BeOne Medicines AG Market Cap
BeOne Medicines AG has a market cap or net worth of 336.45 billion as of October 21, 2026. It is the 583rd most valuable company in the world and the 27th biggest in Hong Kong. Its market cap has increased by 24.56% in one year.
Market Cap
336.45B
Enterprise Value
312.53B
Revenue
48.06B
Global Rank
Country Rank
#27 Hong Kong
PE Ratio
66.97
ChartMarket Cap Chart
Since February 3, 2016, BeOne Medicines AG's market cap has increased from 6.70B to 336.45B, an increase of 4,924.10%. That is a compound annual growth rate of 44.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 336.45B | 28.58% |
| Dec 31, 2025 | 261.67B | 71.29% |
| Dec 31, 2024 | 152.77B | 4.09% |
| Dec 29, 2023 | 146.76B | -17.60% |
| Dec 30, 2022 | 178.11B | -17.96% |
| Dec 31, 2021 | 217.12B | 19.19% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 197.80B |
| Innovent Biologics | 155.03B |
| Sichuan Kelun-Biotech Biopharmaceutical | 108.04B |
| Sino Biopharmaceutical | 93.50B |
| Akeso | 84.10B |
| Genscript Biotech | 75.94B |
| RemeGen | 55.18B |
| Biocytogen Pharmaceuticals (Beijing) | 39.34B |